N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors (Brevetto)

Type
Label
  • N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors (Brevetto) (literal)
Anno
  • 2004-01-01T00:00:00+01:00 (literal)
Alternative label
  • Bisogno T, Della Valle F, De Petrocellis L, Di Marzo V, Marcolongo G, Melck D (2004)
    N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors
    (literal)
Titolo
  • N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Bisogno T, Della Valle F, De Petrocellis L, Di Marzo V, Marcolongo G, Melck D (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#proprieta
  • Innovet Italia S.R.L., Consiglio Nazionale Delle Richerche (literal)
Http://www.cnr.it/ontology/cnr/brevetti.owl#tipoDiBrevetto
  • Internazionale (literal)
Numero brevetto
  • US 7244767 B2 (literal)
Anno di deposito
  • 2004 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Istituto per la Chimica Molecole di Interesse Biologico e Istituto di Cibernetica, CNR, Arco Felice, Napoli, Italy. Innovet Italia S.R.L., (literal)
Titolo
  • N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors (literal)
Http://www.cnr.it/ontology/cnr/brevetti.owl#annoDiConcessione
  • 2007 (literal)
Abstract
  • The present invention relates to the use of N-acylvanillinamide derivatives capable of activating the peripheral receptor CB1 of cannabinoids. In particular, the present invention relates to the use of compounds of general formula (I) in which the meanings of R, R1, R3 and Y are as defined in the description, for the preparation of a medicinal product which is capable of activating the peripheral receptor CB1 of cannabinoids (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it